Class II · Moderate risk
Eletriptan Hydrobromide Tablets 20 mg* 6
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Is Eletriptan recalled?
Not under an active recall.
Eletriptan was recalled 3 times in the past — all now closed. Most recent: Mar 15, 2021.
Most common reason: Labeling / mix-up (1 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Eletriptan. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Eletriptan recalls on record
none so far in 2026; 3 on record, newest first
Class II · Moderate risk
RELPAX (eletriptan HBr)
Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.
Class III · Low risk
Relpax (eletriptan HBr)
Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.